Cameroon, Unitaid Catalyzing Pediatric TB Innovations (CaP TB)

Overview

In Cameroon, about 6,000 children under the age of 15 years old develop TB each year. The Unitaid-funded CaP TB Project was implemented in Cameroon as well as eight other sub-African countries and India, with the goal of reducing the morbidity and mortality caused by pediatric TB. Though CaP TB, EGPAF worked to provide better care for children with TB through the following objectives:

• Improve the regulatory and political environment in favor of pediatric TB.
• Increase the demand for anti-TB treatment through improved case detection.
• Increase the uptake and access to improved pediatric TB treatments for active and latent TB
• Generate novel evidence and data on cost- effectiveness
• Ensure an effective and sustainable transition from the project to the national program

Unitaid is a global health agency engaged in finding innovative solutions to prevent, diagnose and treat diseases more quickly, cheaply and effectively, in low- and middle-income countries. Our work includes funding initiatives to address major diseases such as HIV/AIDS, malaria and tuberculosis, as well as HIV co-infections and co-morbidities such as cervical cancer and hepatitis C, and cross-cutting areas, such as fever management. 

Unitaid is now applying its expertise to address challenges in advancing new therapies and diagnostics for the COVID-19 pandemic, serving as a key member of the Access to COVID Tools Accelerator. Unitaid is hosted by the World Health Organization.